25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

Brain+ ApS
Buy, Hold or Sell?

Let's analyze Brain+ ApS together

I guess you are interested in Brain+ ApS. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Brain+ ApS. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Brain+ ApS

I send you an email if I find something interesting about Brain+ ApS.

1. Quick Overview

1.1. Quick analysis of Brain+ ApS (30 sec.)










1.2. What can you expect buying and holding a share of Brain+ ApS? (30 sec.)

How much money do you get?

How much money do you get?
kr0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
kr0.06
Expected worth in 1 year
kr-0.02
How sure are you?
37.5%

+ What do you gain per year?

Total Gains per Share
kr-0.08
Return On Investment
-76.2%

For what price can you sell your share?

Current Price per Share
kr0.10
Expected price per share
kr0.075 - kr0.102
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Brain+ ApS (5 min.)




Live pricePrice per Share (EOD)
kr0.10
Intrinsic Value Per Share
kr-1.50 - kr-1.37
Total Value Per Share
kr-1.44 - kr-1.31

2.2. Growth of Brain+ ApS (5 min.)




Is Brain+ ApS growing?

Current yearPrevious yearGrowGrow %
How rich?$1.7m$2.3m-$567.3k-32.3%

How much money is Brain+ ApS making?

Current yearPrevious yearGrowGrow %
Making money-$2.7m-$1.3m-$1.3m-49.4%
Net Profit Margin-813.0%-299.4%--

How much money comes from the company's main activities?

2.3. Financial Health of Brain+ ApS (5 min.)




2.4. Comparing to competitors in the Health Information Services industry (5 min.)




  Industry Rankings (Health Information Services)  

3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Brain+ ApS?

Welcome investor! Brain+ ApS's management wants to use your money to grow the business. In return you get a share of Brain+ ApS.

First you should know what it really means to hold a share of Brain+ ApS. And how you can make/lose money.

Speculation

The Price per Share of Brain+ ApS is kr0.0988. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Brain+ ApS.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Brain+ ApS, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is kr0.06. Based on the TTM, the Book Value Change Per Share is kr-0.02 per quarter. Based on the YOY, the Book Value Change Per Share is kr-0.02 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is kr0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Brain+ ApS.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 kr% of Price per Sharekr% of Price per Sharekr% of Price per Sharekr% of Price per Sharekr% of Price per Share
Usd Eps-0.01-12.9%-0.01-12.9%-0.01-6.5%-0.01-5.2%0.00-3.4%
Usd Book Value Change Per Share0.00-2.7%0.00-2.7%0.00-2.9%0.000.8%0.001.0%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share0.00-2.7%0.00-2.7%0.00-2.9%0.000.8%0.001.0%
Usd Price Per Share0.03-0.03-0.24-0.15-0.09-
Price to Earnings Ratio-2.16--2.16--37.55--28.47--17.80-
Price-to-Total Gains Ratio-10.31--10.31--86.10--19.17--19.17-
Price to Book Ratio3.33-3.33-22.18-12.16-7.60-
Price-to-Total Gains Ratio-10.31--10.31--86.10--19.17--19.17-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.01401972
Number of shares71328
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.000.00
Usd Total Gains Per Share0.000.00
Gains per Quarter (71328 shares)-190.4058.57
Gains per Year (71328 shares)-761.59234.28
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-762-7720234224
20-1523-15340469458
30-2285-22960703692
40-3046-30580937926
50-3808-3820011711160
60-4570-4582014061394
70-5331-5344016401628
80-6093-6106018741862
90-6854-6868021092096
100-7616-7630023432330

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%0.03.00.00.0%0.05.00.00.0%0.08.00.00.0%0.08.00.00.0%
Book Value Change Per Share0.01.00.00.0%1.02.00.033.3%1.04.00.020.0%3.05.00.037.5%3.05.00.037.5%
Dividend per Share0.00.01.00.0%0.00.03.00.0%0.00.05.00.0%0.00.08.00.0%0.00.08.00.0%
Total Gains per Share0.01.00.00.0%1.02.00.033.3%1.04.00.020.0%3.05.00.037.5%3.05.00.037.5%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Brain+ ApS compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.019-0.0190%-0.020+6%0.006-425%0.007-358%
Book Value Per Share--0.0580.0580%0.077-24%0.051+14%0.043+35%
Current Ratio--1.0271.0270%1.187-13%0.582+77%0.560+84%
Debt To Asset Ratio--0.6560.6560%0.639+3%0.731-10%0.678-3%
Debt To Equity Ratio--1.9041.9040%1.769+8%5.196-63%3.861-51%
Dividend Per Share----0%-0%-0%-0%
Eps---0.090-0.0900%-0.046-49%-0.036-60%-0.024-74%
Free Cash Flow Per Share---0.081-0.0810%-0.043-47%-0.039-52%-0.018-77%
Free Cash Flow To Equity Per Share---0.016-0.0160%-0.017+8%0.002-769%0.012-229%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max---1.368--------
Intrinsic Value_10Y_min---1.500--------
Intrinsic Value_1Y_max---0.060--------
Intrinsic Value_1Y_min---0.088--------
Intrinsic Value_3Y_max---0.240--------
Intrinsic Value_3Y_min---0.320--------
Intrinsic Value_5Y_max---0.490--------
Intrinsic Value_5Y_min---0.611--------
Market Cap20998952.000-96%41232760.00041232760.0000%363443400.000-89%226312592.000-82%141445370.000-71%
Net Profit Margin---8.130-8.1300%-2.994-63%-2.679-67%-1.726-79%
Operating Margin---8.396-8.3960%-3.438-59%-2.817-66%-1.824-78%
Operating Ratio--1.6671.6670%-4.429+366%-0.607+136%0.041+3938%
Pb Ratio1.696-96%3.3293.3290%22.184-85%12.159-73%7.599-56%
Pe Ratio-1.098+49%-2.156-2.1560%-37.547+1642%-28.475+1221%-17.797+725%
Price Per Share0.099-96%0.1940.1940%1.710-89%1.065-82%0.666-71%
Price To Free Cash Flow Ratio-1.219+49%-2.394-2.3940%-40.163+1577%-17.747+641%-11.092+363%
Price To Total Gains Ratio-5.252+49%-10.313-10.3130%-86.101+735%-19.171+86%-19.171+86%
Quick Ratio--0.7260.7260%0.906-20%0.465+56%0.475+53%
Return On Assets---0.532-0.5320%-0.213-60%-0.200-62%-0.137-74%
Return On Equity---1.544-1.5440%-0.591-62%-0.724-53%-0.481-69%
Total Gains Per Share---0.019-0.0190%-0.020+6%0.006-425%0.007-358%
Usd Book Value--1757396.8761757396.8760%2324733.794-24%1546331.865+14%1303697.310+35%
Usd Book Value Change Per Share---0.003-0.0030%-0.003+6%0.001-425%0.001-358%
Usd Book Value Per Share--0.0080.0080%0.011-24%0.007+14%0.006+35%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.013-0.0130%-0.006-49%-0.005-60%-0.003-74%
Usd Free Cash Flow---2443588.808-2443588.8080%-1284068.993-47%-1183535.142-52%-481620.466-80%
Usd Free Cash Flow Per Share---0.011-0.0110%-0.006-47%-0.006-52%-0.003-77%
Usd Free Cash Flow To Equity Per Share---0.002-0.0020%-0.002+8%0.000-769%0.002-229%
Usd Market Cap2979751.289-96%5850928.6445850928.6440%51572618.460-89%32113756.805-82%20071098.003-71%
Usd Price Per Share0.014-96%0.0280.0280%0.243-89%0.151-82%0.094-71%
Usd Profit---2713811.249-2713811.2490%-1373534.531-49%-1097629.478-60%-711467.302-74%
Usd Revenue--333818.473333818.4730%458708.352-27%591959.178-44%588819.602-43%
Usd Total Gains Per Share---0.003-0.0030%-0.003+6%0.001-425%0.001-358%
 EOD+3 -5MRQTTM+0 -0YOY+9 -245Y+10 -2310Y+10 -23

3.3 Fundamental Score

Let's check the fundamental score of Brain+ ApS based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-1.098
Price to Book Ratio (EOD)Between0-11.696
Net Profit Margin (MRQ)Greater than0-8.130
Operating Margin (MRQ)Greater than0-8.396
Quick Ratio (MRQ)Greater than10.726
Current Ratio (MRQ)Greater than11.027
Debt to Asset Ratio (MRQ)Less than10.656
Debt to Equity Ratio (MRQ)Less than11.904
Return on Equity (MRQ)Greater than0.15-1.544
Return on Assets (MRQ)Greater than0.05-0.532
Total2/10 (20.0%)

3.4 Technical Score

Let's check the technical score of Brain+ ApS based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5054.435
Ma 20Greater thanMa 500.095
Ma 50Greater thanMa 1000.092
Ma 100Greater thanMa 2000.097
OpenGreater thanClose0.090
Total2/5 (40.0%)

4. In-depth Analysis

4.1 About Brain+ ApS

Brain+ A/S develops digital therapeutics for Alzheimer's and dementia. The company's product pipeline includes cognitive stimulation therapy (CST) - Therapist Companion, an application that enables therapists to deliver CST while saving significant preparation time; CST - Home Companion, a digital health application to provide repeat exposure to the CST program in an at-home setting during and after participation in a therapist facilitated CST program; CST - Home Care, a solution to enable people with dementia to continue to receive maintenance benefits from CST therapy after completion of the seven-week basic CST group program; and CST for mild cognitive impairment (MCI), a solution for individuals with MCI, offering an adapted version of CST to address their unique needs. It also develops Computerized Cognitive Training, a cognitive training method for patients with mild cognitive impairment; and Starry Night, a memory test designed to identify early signs of Alzheimer's disease. The company was incorporated in 2012 and is based in Copenhagen, Denmark.

Fundamental data was last updated by Penke on 2024-11-25 20:36:03.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is just able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is just able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is fair priced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Brain+ ApS earns for each kr1 of revenue.

  • Above 10% is considered healthy but always compare Brain+ ApS to the Health Information Services industry mean.
  • A Net Profit Margin of -813.0% means that kr-8.13 for each kr1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Brain+ ApS:

  • The MRQ is -813.0%. The company is making a huge loss. -2
  • The TTM is -813.0%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-813.0%TTM-813.0%0.0%
TTM-813.0%YOY-299.4%-513.5%
TTM-813.0%5Y-267.9%-545.0%
5Y-267.9%10Y-172.6%-95.4%
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
MRQ-813.0%-18.5%-794.5%
TTM-813.0%-18.9%-794.1%
YOY-299.4%-17.8%-281.6%
5Y-267.9%-30.4%-237.5%
10Y-172.6%-34.1%-138.5%
4.3.1.2. Return on Assets

Shows how efficient Brain+ ApS is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Brain+ ApS to the Health Information Services industry mean.
  • -53.2% Return on Assets means that Brain+ ApS generated kr-0.53 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Brain+ ApS:

  • The MRQ is -53.2%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -53.2%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-53.2%TTM-53.2%0.0%
TTM-53.2%YOY-21.3%-31.8%
TTM-53.2%5Y-20.0%-33.1%
5Y-20.0%10Y-13.7%-6.4%
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
MRQ-53.2%-3.8%-49.4%
TTM-53.2%-4.0%-49.2%
YOY-21.3%-4.5%-16.8%
5Y-20.0%-4.8%-15.2%
10Y-13.7%-5.2%-8.5%
4.3.1.3. Return on Equity

Shows how efficient Brain+ ApS is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Brain+ ApS to the Health Information Services industry mean.
  • -154.4% Return on Equity means Brain+ ApS generated kr-1.54 for each kr1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Brain+ ApS:

  • The MRQ is -154.4%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -154.4%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-154.4%TTM-154.4%0.0%
TTM-154.4%YOY-59.1%-95.3%
TTM-154.4%5Y-72.4%-82.0%
5Y-72.4%10Y-48.1%-24.3%
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
MRQ-154.4%-2.4%-152.0%
TTM-154.4%-4.2%-150.2%
YOY-59.1%-5.6%-53.5%
5Y-72.4%-8.0%-64.4%
10Y-48.1%-8.3%-39.8%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Brain+ ApS.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Brain+ ApS is operating .

  • Measures how much profit Brain+ ApS makes for each kr1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Brain+ ApS to the Health Information Services industry mean.
  • An Operating Margin of -839.6% means the company generated kr-8.40  for each kr1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Brain+ ApS:

  • The MRQ is -839.6%. The company is operating very inefficient. -2
  • The TTM is -839.6%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-839.6%TTM-839.6%0.0%
TTM-839.6%YOY-343.8%-495.8%
TTM-839.6%5Y-281.7%-557.9%
5Y-281.7%10Y-182.4%-99.3%
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
MRQ-839.6%-18.7%-820.9%
TTM-839.6%-21.7%-817.9%
YOY-343.8%-12.4%-331.4%
5Y-281.7%-16.4%-265.3%
10Y-182.4%-25.7%-156.7%
4.3.2.2. Operating Ratio

Measures how efficient Brain+ ApS is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Health Information Services industry mean).
  • An Operation Ratio of 1.67 means that the operating costs are kr1.67 for each kr1 in net sales.

Let's take a look of the Operating Ratio trends of Brain+ ApS:

  • The MRQ is 1.667. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.667. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.667TTM1.6670.000
TTM1.667YOY-4.429+6.096
TTM1.6675Y-0.607+2.274
5Y-0.60710Y0.041-0.648
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
MRQ1.6671.274+0.393
TTM1.6671.298+0.369
YOY-4.4291.376-5.805
5Y-0.6071.299-1.906
10Y0.0411.311-1.270
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Brain+ ApS.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Brain+ ApS is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Health Information Services industry mean).
  • A Current Ratio of 1.03 means the company has kr1.03 in assets for each kr1 in short-term debts.

Let's take a look of the Current Ratio trends of Brain+ ApS:

  • The MRQ is 1.027. The company is just able to pay all its short-term debts.
  • The TTM is 1.027. The company is just able to pay all its short-term debts.
Trends
Current periodCompared to+/- 
MRQ1.027TTM1.0270.000
TTM1.027YOY1.187-0.159
TTM1.0275Y0.582+0.446
5Y0.58210Y0.560+0.022
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
MRQ1.0271.663-0.636
TTM1.0271.731-0.704
YOY1.1871.900-0.713
5Y0.5822.645-2.063
10Y0.5602.637-2.077
4.4.3.2. Quick Ratio

Measures if Brain+ ApS is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Brain+ ApS to the Health Information Services industry mean.
  • A Quick Ratio of 0.73 means the company can pay off kr0.73 for each kr1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Brain+ ApS:

  • The MRQ is 0.726. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.726. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.726TTM0.7260.000
TTM0.726YOY0.906-0.180
TTM0.7265Y0.465+0.261
5Y0.46510Y0.475-0.010
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
MRQ0.7261.119-0.393
TTM0.7261.236-0.510
YOY0.9061.373-0.467
5Y0.4652.261-1.796
10Y0.4752.321-1.846
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Brain+ ApS.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Brain+ ApS assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Brain+ ApS to Health Information Services industry mean.
  • A Debt to Asset Ratio of 0.66 means that Brain+ ApS assets are financed with 65.6% credit (debt) and the remaining percentage (100% - 65.6%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Brain+ ApS:

  • The MRQ is 0.656. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.656. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.656TTM0.6560.000
TTM0.656YOY0.639+0.017
TTM0.6565Y0.731-0.076
5Y0.73110Y0.678+0.053
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
MRQ0.6560.411+0.245
TTM0.6560.407+0.249
YOY0.6390.424+0.215
5Y0.7310.423+0.308
10Y0.6780.416+0.262
4.5.4.2. Debt to Equity Ratio

Measures if Brain+ ApS is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Brain+ ApS to the Health Information Services industry mean.
  • A Debt to Equity ratio of 190.4% means that company has kr1.90 debt for each kr1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Brain+ ApS:

  • The MRQ is 1.904. The company is just able to pay all its debts with equity.
  • The TTM is 1.904. The company is just able to pay all its debts with equity.
Trends
Current periodCompared to+/- 
MRQ1.904TTM1.9040.000
TTM1.904YOY1.769+0.135
TTM1.9045Y5.196-3.292
5Y5.19610Y3.861+1.335
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
MRQ1.9040.565+1.339
TTM1.9040.572+1.332
YOY1.7690.630+1.139
5Y5.1960.618+4.578
10Y3.8610.644+3.217
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every kr1 in earnings Brain+ ApS generates.

  • Above 15 is considered overpriced but always compare Brain+ ApS to the Health Information Services industry mean.
  • A PE ratio of -2.16 means the investor is paying kr-2.16 for every kr1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Brain+ ApS:

  • The EOD is -1.098. Based on the earnings, the company is expensive. -2
  • The MRQ is -2.156. Based on the earnings, the company is expensive. -2
  • The TTM is -2.156. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-1.098MRQ-2.156+1.058
MRQ-2.156TTM-2.1560.000
TTM-2.156YOY-37.547+35.391
TTM-2.1565Y-28.475+26.319
5Y-28.47510Y-17.797-10.678
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
EOD-1.098-1.389+0.291
MRQ-2.156-1.144-1.012
TTM-2.156-1.579-0.577
YOY-37.547-2.827-34.720
5Y-28.475-3.924-24.551
10Y-17.797-4.695-13.102
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Brain+ ApS:

  • The EOD is -1.219. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -2.394. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -2.394. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-1.219MRQ-2.394+1.175
MRQ-2.394TTM-2.3940.000
TTM-2.394YOY-40.163+37.769
TTM-2.3945Y-17.747+15.353
5Y-17.74710Y-11.092-6.655
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
EOD-1.219-0.921-0.298
MRQ-2.394-1.236-1.158
TTM-2.394-1.249-1.145
YOY-40.163-2.945-37.218
5Y-17.747-6.806-10.941
10Y-11.092-4.308-6.784
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Brain+ ApS is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Health Information Services industry mean).
  • A PB ratio of 3.33 means the investor is paying kr3.33 for each kr1 in book value.

Let's take a look of the Price to Book Ratio trends of Brain+ ApS:

  • The EOD is 1.696. Based on the equity, the company is underpriced. +1
  • The MRQ is 3.329. Based on the equity, the company is fair priced.
  • The TTM is 3.329. Based on the equity, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD1.696MRQ3.329-1.634
MRQ3.329TTM3.3290.000
TTM3.329YOY22.184-18.855
TTM3.3295Y12.159-8.829
5Y12.15910Y7.599+4.559
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
EOD1.6961.744-0.048
MRQ3.3291.889+1.440
TTM3.3291.892+1.437
YOY22.1842.172+20.012
5Y12.1594.074+8.085
10Y7.5994.419+3.180
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in DKK. All numbers in thousands.

Summary
Total Assets35,970
Total Liabilities23,585
Total Stockholder Equity12,385
 As reported
Total Liabilities 23,585
Total Stockholder Equity+ 12,385
Total Assets = 35,970

Assets

Total Assets35,970
Total Current Assets4,418
Long-term Assets31,552
Total Current Assets
Cash And Cash Equivalents 3,091
Net Receivables 31
Other Current Assets 350
Total Current Assets  (as reported)4,418
Total Current Assets  (calculated)3,472
+/- 946
Long-term Assets
Property Plant Equipment 67
Intangible Assets 31,552
Long-term Assets  (as reported)31,552
Long-term Assets  (calculated)31,618
+/- 67

Liabilities & Shareholders' Equity

Total Current Liabilities4,300
Long-term Liabilities19,285
Total Stockholder Equity12,385
Total Current Liabilities
Accounts payable 1,086
Other Current Liabilities 472
Total Current Liabilities  (as reported)4,300
Total Current Liabilities  (calculated)1,558
+/- 2,742
Long-term Liabilities
Long-term Liabilities  (as reported)19,285
Long-term Liabilities  (calculated)0
+/- 19,285
Total Stockholder Equity
Common Stock6,546
Retained Earnings -18,772
Accumulated Other Comprehensive Income 24,610
Total Stockholder Equity (as reported)12,385
Total Stockholder Equity (calculated)12,385
+/-0
Other
Capital Stock6,546
Cash and Short Term Investments 3,091
Common Stock Shares Outstanding 39,112
Current Deferred Revenue2,742
Liabilities and Stockholders Equity 35,970
Net Debt -3,091
Net Invested Capital 12,385
Net Working Capital 118



6.2. Balance Sheets Structured

Currency in DKK. All numbers in thousands.

 Trend2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-31
> Total Assets 
9,118
11,146
16,247
22,769
23,810
29,889
46,883
45,372
35,970
35,97045,37246,88329,88923,81022,76916,24711,1469,118
   > Total Current Assets 
1,913
1,954
2,241
2,996
1,400
2,081
13,323
8,416
4,418
4,4188,41613,3232,0811,4002,9962,2411,9541,913
       Cash And Cash Equivalents 
435
1,308
1,603
2,795
633
1,363
9,993
6,402
3,091
3,0916,4029,9931,3636332,7951,6031,308435
       Net Receivables 
1,478
645
18
201
766
718
3,330
22
31
31223,330718766201186451,478
       Other Current Assets 
0
0
624
9
767
0
3,330
323
350
3503233,3300767962400
   > Long-term Assets 
7,205
9,193
14,006
19,772
22,410
27,808
33,560
36,956
31,552
31,55236,95633,56027,80822,41019,77214,0069,1937,205
       Property Plant Equipment 
8
3
12
6
22
31
145
112
67
67112145312261238
       Goodwill 
0
0
0
0
6,122
15,019
0
0
0
00015,0196,1220000
       Intangible Assets 
7,180
9
14
20
17,266
12,758
33,416
36,845
31,552
31,55236,84533,41612,75817,266201497,180
       Other Assets 
0
0
0
0
0
0
0
0
0
000000000
> Total Liabilities 
2,648
5,066
9,550
16,534
20,613
27,971
26,279
28,989
23,585
23,58528,98926,27927,97120,61316,5349,5505,0662,648
   > Total Current Liabilities 
1,099
1,949
6,500
13,564
17,673
24,951
25,088
7,091
4,300
4,3007,09125,08824,95117,67313,5646,5001,9491,099
       Short-term Debt 
0
0
0
0
0
0
0
0
0
000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
000000000
       Accounts payable 
304
355
34
99
2,565
961
1,531
871
1,086
1,0868711,5319612,5659934355304
       Other Current Liabilities 
794
1,594
6,467
13,465
15,108
1,706
1,278
3,484
472
4723,4841,2781,70615,10813,4656,4671,594794
   > Long-term Liabilities 
1,549
3,117
3,049
2,970
2,940
3,020
1,191
21,899
19,285
19,28521,8991,1913,0202,9402,9703,0493,1171,549
       Other Liabilities 
0
3,117
3,049
2,964
0
2,633
1,786
0
0
001,7862,63302,9643,0493,1170
> Total Stockholder Equity
6,470
6,080
6,697
6,235
3,197
1,918
20,604
16,383
12,385
12,38516,38320,6041,9183,1976,2356,6976,0806,470
   Common Stock
106
106
96
96
96
96
1,182
1,572
6,546
6,5461,5721,18296969696106106
   Retained Earnings 
6,365
5,975
4,680
4,381
-14,361
-19,844
-6,642
-13,928
-18,772
-18,772-13,928-6,642-19,844-14,3614,3814,6805,9756,365
   Capital Surplus 000000000
   Treasury Stock000000000
   Other Stockholders Equity 
0
-2
14
14
15,130
-14
26,064
28,739
0
028,73926,064-1415,1301414-20



6.3. Balance Sheets

Currency in DKK. All numbers in thousands.




6.4. Cash Flows

Currency in DKK. All numbers in thousands.




6.5. Income Statements

Currency in DKK. All numbers in thousands.


6.6. Latest Income Statement

Income Statement (annual), 2023-12-31. Currency in DKK. All numbers in thousands.

Gross Profit (+$)
totalRevenue2,352
Cost of Revenue-0
Gross Profit2,3522,352
 
Operating Income (+$)
Gross Profit2,352
Operating Expense-3,921
Operating Income-17,507-1,569
 
Operating Expense (+$)
Research Development3,921
Selling General Administrative0
Selling And Marketing Expenses0
Operating Expense3,9213,921
 
Net Interest Income (+$)
Interest Income20
Interest Expense-2,266
Other Finance Cost-0
Net Interest Income-2,246
 
Pretax Income (+$)
Operating Income-17,507
Net Interest Income-2,246
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-19,752-15,261
EBIT - interestExpense = -22,018
-19,752
-16,859
Interest Expense2,266
Earnings Before Interest and Taxes (EBIT)-19,752-17,487
Earnings Before Interest and Taxes (EBITDA)-14,854
 
After tax Income (+$)
Income Before Tax-19,752
Tax Provision--628
Net Income From Continuing Ops-19,125-19,125
Net Income-19,125
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses19,859
Total Other Income/Expenses Net-2,2462,246
 

Technical Analysis of Brain+ ApS
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Brain+ ApS. The general trend of Brain+ ApS is BEARISH with 14.3% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Brain+ ApS's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-14.3%) Bearish trend (14.3%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Brain+ ApS.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 0.102 < 0.102 < 0.102.

The bearish price targets are: 0.0882 > 0.085 > 0.075.

Tweet this
Brain+ ApS Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Brain+ ApS. The current mas is .

The long score for the Moving Averages is 6/14.
The longshort score for the Moving Averages is -2/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Brain+ ApS Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Brain+ ApS. The current macd is 0.00037512.

The long score for the Moving Average Convergence/Divergence (MACD) is 2/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 0/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Brain+ ApS price going down in the near term. -2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Brain+ ApS. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Brain+ ApS price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Brain+ ApS Daily Moving Average Convergence/Divergence (MACD) ChartBrain+ ApS Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Brain+ ApS. The current adx is 41.75.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -3/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Brain+ ApS shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX > 25 && ADX trending down: The ADX is above 25 and indicates a strong bearish trend. The ADX is declining, the bearish trend is weakening. Could be a potential reversal to the upside. -2
Brain+ ApS Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Brain+ ApS. The current sar is 0.08038025.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Brain+ ApS Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Brain+ ApS. The current rsi is 54.43. The current phase is Correction in bear market.

The long score for the Relative Strength Index (RSI) is 4/13.
The longshort score for the Relative Strength Index (RSI) is 4/(-13 +13).

  • Correction in bear market: Extended price decline in a downtrend, significant pullback. Consider reducing exposure, wait for signs of trend reversal.
  • Trending up: The RSI is trending up. +1
Brain+ ApS Daily Relative Strength Index (RSI) ChartBrain+ ApS Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Brain+ ApS. The current phase is Overbought in bear market.

The long score for the Stochastic Oscillator is 6/6.
The longshort score for the Stochastic Oscillator is 6/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH > 80: The STOCH %K is above 80 and overbought. +2
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Brain+ ApS price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Brain+ ApS Daily Stochastic Oscillator ChartBrain+ ApS Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Brain+ ApS. The current cci is 79.23.

Brain+ ApS Daily Commodity Channel Index (CCI) ChartBrain+ ApS Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Brain+ ApS. The current cmo is 13.65.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Brain+ ApS Daily Chande Momentum Oscillator (CMO) ChartBrain+ ApS Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Brain+ ApS. The current willr is -18.82352941.

The long score for the Williams %R is 1/1.
The longshort score for the Williams %R is 1/(-1 +1).

  • WILLR > -20: The Williams %R is above -20. This indicates that the price is in overbought territory, suggesting a potential price correction or trend reversal to the downside. +1
Brain+ ApS Daily Williams %R ChartBrain+ ApS Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Brain+ ApS.

Brain+ ApS Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Brain+ ApS. The current atr is 0.00793832.

Brain+ ApS Daily Average True Range (ATR) ChartBrain+ ApS Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Brain+ ApS. The current obv is -18,941,433.

Brain+ ApS Daily On-Balance Volume (OBV) ChartBrain+ ApS Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Brain+ ApS. The current mfi is 77.56.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Brain+ ApS Daily Money Flow Index (MFI) ChartBrain+ ApS Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Brain+ ApS.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-07-17DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-07-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-22DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-07-23STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-24STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-25CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-07-29STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-07-31DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-08-02STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-08-05STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-08-06STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-08-07DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-08-08STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-09WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-08-12DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-08-13STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-08-14DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-08-15DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-08-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-20STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-21DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-22DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-08-23STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-26DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-08-27SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-08-28MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-08-30STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-03CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-09-04STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-09-10DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-09-11CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-09-12CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-09-16MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-09-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-20STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-23STOCH SHORT EXITThe %K line crosses above the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-09-24MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-09-26DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-09-27MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-09-30STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-01MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-10-02MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-04STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-07DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-10-08CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-10-09WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-10-10STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-15STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-10-17CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-10-21DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-28STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-10-30STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-10-31STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-11-01MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-11-06SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-11-07STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-08STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-11-11STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-11-14MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-11-15MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-11-19STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-11-20CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-11-22CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-11-25MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-11-26MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-11-28STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-29CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside

6.3. Candlestick Patterns

Brain+ ApS Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Brain+ ApS based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5054.435
Ma 20Greater thanMa 500.095
Ma 50Greater thanMa 1000.092
Ma 100Greater thanMa 2000.097
OpenGreater thanClose0.090
Total2/5 (40.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Brain+ ApS with someone you think should read this too:
  • Are you bullish or bearish on Brain+ ApS? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Brain+ ApS? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Brain+ ApS

I send you an email if I find something interesting about Brain+ ApS.


Comments

How you think about this?

Leave a comment

Stay informed about Brain+ ApS.

Receive notifications about Brain+ ApS in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.